Xenon Pharmaceuticals (STU:XP0) FFO


STU:XP0 Xenon Pharmaceuticals Inc STU:XP0
20 GF Score
Price €60.00
GF Value €0.14
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

STU:XP0
20GF Score
Xenon Pharmaceuticals Inc STU:XP0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Xenon Pharmaceuticals (STU:XP0) Overvalued in 2026?

Based on GuruFocus' analysis, Xenon Pharmaceuticals stock appears to be overvalued. The current stock price of €60.00 is trading 42757.1% above its estimated GF Value™ of €0.14. GuruFocus considers Xenon Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for STU:XP0:

  • FFO:
  • GF Value™: €0.14 vs. price of €60.00 (42757.1% above fair value)
  • GF Score™: 20/100 with 5 warning signs

No single metric tells the full story. See the STU:XP0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xenon Pharmaceuticals Business Description

Other Exchanges XENE:USA
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
20GF Score

Get the complete analysis for STU:XP0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.00
Price
€0.14
GF Value